Mr. Thurman brings over 35 years’ experience in executive leadership, M&A, and corporate governance. As a CEO, he has broad experience in the healthcare industry specifically biopharmaceuticals, medical devices, and clinical diagnostics. Additionally, he brings a global perspective having started and operated businesses in North America, Europe, Asia, the Middle East and Latin America. Early in his career, he was Director and President of Rhone-Poulenc Rorer Pharmaceuticals Inc. Subsequently, he became Chairman and CEO of Corning Life Sciences, that spun off both Quest Diagnostics and Covance. He then founded and was Chairman & CEO of VIASYS Healthcare Inc., a global leader in respiratory and neuro diagnostics, critical care systems and orthopedics. Randy has extensive experience working with private equity firms and has participated in transactions globally. He is currently Executive Chairman, Outlook Therapeutics Inc., Vice Chairman, Syntone BioPharma Inc., and Senior Advisor to Telesair, Inc. He is also on the Board of Villanova Law School and the Center for Law and Entrepreneurialism. Randy has served on numerous boards and has published several articles on corporate governance. Prior to his corporate career he served as a combat pilot in the U.S. Air Force and is currently on the board of Distinguished Flying Cross Society. Randy graduated from Virginia Polytechnic Institute with a BS in Economics; Webster University with an MA in Management; and is a graduate of the USAF Air Command and Staff College.
